Pathogen Distribution, Drug Resistance Risk Factors, and Construction of Risk Prediction Model for Drug-Resistant Bacterial Infection in Hospitalized Patients at the Respiratory Department During the COVID-19 Pandemic

References

• Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.
   PubMed Web of Science ®Google Scholar
• Ding L, Yang Y, Zheng C, et al. Activities of eravacycline, tedizolid, norvancomycin, nemonoxacin, ceftaroline, and comparators against 1871 Staphylococcus and 1068 Enterococcus species isolates from china: updated report of the CHINET study 2019. Microbiol Spectr. 2022;10(6):e0171522. doi:10.1128/spectrum.01715-22
   PubMed Web of Science ®Google Scholar
• Oliveira J, Reygaert WC. Gram Negative Bacteria. Treasure Island (FL): StatPearls; 2022.
   Google Scholar
• Troeger C, Forouzanfar M, Rao PC. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the global burden of disease study 2015. Lancet Infect Dis. 2017;17(11):1133–1161. doi:10.1016/S1473-3099(17)30396-1
   PubMed Web of Science ®Google Scholar
• Duan N, Du J, Huang C, Li H. Microbial distribution and antibiotic susceptibility of lower respiratory tract infections patients from pediatric ward, adult respiratory ward, and respiratory intensive care unit. Front Microbiol. 2020;11:1480. doi:10.3389/fmicb.2020.01480
   PubMed Web of Science ®Google Scholar
• Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2021;27(1):9–11. doi:10.1016/j.cmi.2020.09.025
   PubMed Web of Science ®Google Scholar
• Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021;57(4):106324. doi:10.1016/j.ijantimicag.2021.106324
   PubMed Web of Science ®Google Scholar
• Kozak R, Prost K, Yip L, Williams V, Leis JA, Mubareka S. Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario. J Clin Virol. 2020;126:104338. doi:10.1016/j.jcv.2020.104338
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):769–777. doi:10.1093/cid/ciaa272
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–2468.
   PubMed Web of Science ®Google Scholar
• Nieuwlaat R, Mbuagbaw L, Mertz D, et al. Coronavirus disease 2019 and antimicrobial resistance: parallel and interacting health emergencies. Clin Infect Dis. 2021;72(9):1657–1659. doi:10.1093/cid/ciaa773
   PubMed Web of Science ®Google Scholar
• Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303–1312. doi:10.1016/S0140-6736(22)00462-7
   PubMed Web of Science ®Google Scholar
• Prevention CCfDCa. The situation of the novel coronavirus infection in China; 2023. Available from: https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202301/t20230115_263381.html. Accessed January 15, 2023.
   Google Scholar
• Healthcare-associated Infection Control Branch of Chinese Preventive Medicine Association. Guidelines for collection and submission of clinical microbiological specimens. Chin J Nosocomiology. 2018;28(20):3192–3200.
   Google Scholar
• Humphries R, Bobenchik AM, Hindler JA, Schuetz AN, McAdam AJ. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st edition. J Clin Microbiol. 2021;59(12):e0021321. doi:10.1128/JCM.00213-21
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Network CAS. China antimicrobial surveillance network; 2021. Available from: http://www.chinets.com/Data/AntibioticDrugFast. Accessed February 15, 2023.
   Google Scholar
• Hu F. CHINET surveillance of bacterial resistance: results of 2020. Chin J Infect Chemother. 2021;21(04):377–387.
   Google Scholar
• Hu F. CHINET surveillance of bacterial resistance across tertiary hospitals in 2019. Chin J Infect Chemother. 2020;20(3):233–243.
   Google Scholar
• Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis. 2019;69(Suppl 7):S521–S528. doi:10.1093/cid/ciz824
   PubMed Web of Science ®Google Scholar
• Cerceo E, Deitelzweig SB, Sherman BM, Amin AN. Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options. Microb Drug Resist. 2016;22(5):412–431. doi:10.1089/mdr.2015.0220
   PubMed Web of Science ®Google Scholar
• Morris S, Cerceo E. Trends, epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics. 2020;9(4):196.
   Google Scholar
• Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–88. doi:10.1016/j.cmi.2020.07.041
   PubMed Web of Science ®Google Scholar
• Tiri B, Sensi E, Marsiliani V, et al. Antimicrobial stewardship program, COVID-19, and infection control: spread of carbapenem-resistant Klebsiella pneumoniae colonization in ICU COVID-19 Patients. What Did Not Work? J Clin Med. 2020;9(9):2744.
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Yang Y, et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control. 2020;9(1):153. doi:10.1186/s13756-020-00819-1
   PubMed Web of Science ®Google Scholar
• Fritzenwanker M, Imirzalioglu C, Herold S, Wagenlehner FM, Zimmer KP, Chakraborty T. Treatment options for carbapenem- resistant gram-negative infections. Dtsch Arztebl Int. 2018;115(20–21):345–352.
   PubMed Web of Science ®Google Scholar
• Tian Y, Zhang Q, Wen L, Chen J, Van Tyne D. Combined effect of polymyxin B and tigecycline to overcome heteroresistance in carbapenem-resistant Klebsiella pneumoniae. Microbiol Spectr. 2021;9(2):e0015221. doi:10.1128/Spectrum.00152-21
   PubMed Web of Science ®Google Scholar
• Ramirez MS, Tolmasky ME. Amikacin: uses, resistance, and prospects for inhibition. Molecules. 2017;22(12):2267.
   PubMed Web of Science ®Google Scholar
• Jean SS, Harnod D, Hsueh PR. Global threat of carbapenem-resistant gram-negative bacteria. Front Cell Infect Microbiol. 2022;12:823684. doi:10.3389/fcimb.2022.823684
   PubMed Web of Science ®Google Scholar
• Boral B, Unaldi O, Ergin A, Durmaz R, Eser OK, Acinetobacter Study G. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features. Ann Clin Microbiol Antimicrob. 2019;18(1):19. doi:10.1186/s12941-019-0319-8
   PubMedGoogle Scholar
• Wang Z, Qin RR, Huang L, Sun LY. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae Infection. Chin Med J. 2018;131(1):56–62. doi:10.4103/0366-6999.221267
   PubMed Web of Science ®Google Scholar
• Alhussain FA, Yenugadhati N, Al Eidan FA, Al Johani S, Badri M. Risk factors, antimicrobial susceptibility pattern and patient outcomes of Pseudomonas aeruginosa infection: a matched case-control study. J Infect Public Health. 2021;14(1):152–157. doi:10.1016/j.jiph.2020.11.010
   PubMed Web of Science ®Google Scholar
• Palavutitotai N, Jitmuang A, Tongsai S, Kiratisin P, Angkasekwinai N, Shafer WM. Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections. PLoS One. 2018;13(2):e0193431. doi:10.1371/journal.pone.0193431
   PubMed Web of Science ®Google Scholar
• Yang X, Guo R, Xie B, et al. Drug resistance of pathogens causing nosocomial infection in orthopedics from 2012 to 2017: a 6-year retrospective study. J Orthop Surg Res. 2021;16(1):100. doi:10.1186/s13018-021-02234-7
   PubMed Web of Science ®Google Scholar
• Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1–13. doi:10.1016/j.idc.2013.09.003
   PubMed Web of Science ®Google Scholar
• Feifer A, Corcos J. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourol Urodyn. 2008;27(6):475–479. doi:10.1002/nau.20569
   PubMed Web of Science ®Google Scholar
• Sedor J, Mulholland SG. Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am. 1999;26(4):821–828. doi:10.1016/S0094-0143(05)70222-6
   PubMed Web of Science ®Google Scholar
• Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018;8:4. doi:10.3389/fcimb.2018.00004
   PubMed Web of Science ®Google Scholar
• Chabi ML, Goracci A, Roche N, Paugam A, Lupo A, Revel MP. Pulmonary aspergillosis. Diagn Interv Imaging. 2015;96(5):435–442. doi:10.1016/j.diii.2015.01.005
   PubMed Web of Science ®Google Scholar
• Tiew PY, Thng KX, Chotirmall SH. Clinical Aspergillus signatures in COPD and bronchiectasis. J Fungi. 2022;8(5):480. doi:10.3390/jof8050480
   Web of Science ®Google Scholar
• Laws M, Shaaban A, Rahman KM. Antibiotic resistance breakers: current approaches and future directions. FEMS Microbiol Rev. 2019;43(5):490–516. doi:10.1093/femsre/fuz014
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 1999;12(4):501–517. doi:10.1128/CMR.12.4.501
   PubMed Web of Science ®Google Scholar
• Liu P, Li X, Luo M, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. Microb Drug Resist. 2018;24(2):190–198. doi:10.1089/mdr.2017.0061
   PubMed Web of Science ®Google Scholar
• Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:79. doi:10.1186/s13756-018-0370-9
   PubMed Web of Science ®Google Scholar
• Betjes MG, Meijers RW, Litjens NH. Loss of renal function causes premature aging of the immune system. Blood Purif. 2013;36(3–4):173–178. doi:10.1159/000356084
   PubMed Web of Science ®Google Scholar
• Poinen K, Quinn RR, Clarke A, et al. Complications from tunneled hemodialysis catheters: a Canadian observational cohort study. Am J Kidney Dis. 2019;73(4):467–475. doi:10.1053/j.ajkd.2018.10.014
   PubMed Web of Science ®Google Scholar
• Li L, Li X, Xia Y, et al. Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy. Front Pharmacol. 2020;11:786. doi:10.3389/fphar.2020.00786
   PubMed Web of Science ®Google Scholar
• Eyler RF, Shvets K. Clinical pharmacology of antibiotics. Clin J Am Soc Nephrol. 2019;14(7):1080–1090. doi:10.2215/CJN.08140718
   PubMed Web of Science ®Google Scholar
• Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95–107. doi:10.1016/S1473-3099(17)30592-3
   PubMed Web of Science ®Google Scholar
• Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57(9):1308–1318. doi:10.1515/cclm-2018-1181
   PubMed Web of Science ®Google Scholar
• Huespe I, Prado E, Staneloni I, et al. Cinética de procalcitonina en infecciones causadas por bacterias multirresistentes [Kinetics of procalcitonin in infections caused by multidrug-resistant bacteria]. Medicina. 2020;80(6):599–605. Spanish.
   PubMedGoogle Scholar